Zandelisib
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Zandelisib is an investigational new drug that is being evaluated to treat follicular lymphoma. It is a phosphatidylinositol 3 kinase delta inhibitor.
Zandelisib is an investigational new drug that is being evaluated to treat follicular lymphoma. It is a phosphatidylinositol 3 kinase delta inhibitor.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330641896 under CC BY-SA 4.0; modifications have been made.